Ask AI

Search

Updates

Loading...

Table of contents

Scleredema

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of scleredema are prepared by our editorial team based on guidelines from the European Academy of Dermatology and Venereology (EADV 2017).
1

Screening and diagnosis

Diagnosis
As per EADV 2017 guidelines:
Diagnose scleredema clinically.
E
Perform a histopathologic examination to confirm a definitive diagnosis.
E
Create free account

Medical management

Indications for treatment
As per EADV 2017 guidelines:
Do not initiate treatment in patients with type 1 scleredema, as it is self-limited and usually resolves in a short period of time.
D
Initiate treatment for an underlying condition in patients with types 2 and 3 scleredema.
E

More topics in this section

  • Treatment options

  • Glycemic control

Follow-up and surveillance

Follow-up: as per EADV 2017 guidelines, follow-up patients with types 2 and 3 scleredema to screen for paraproteinemia and systemic complications.
E